Evidence mapPaperPMID 39769118Full record

ArticleInternational journal of molecular sciences2024

Caryophyllene Oxide, a Bicyclic Terpenoid Isolated from

Jesica Ramírez-Santos, Fernando Calzada, Normand García-Hernández, Elizabeth Barbosa, Claudia Velázquez, Miguel Valdes

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Immunomodulatory Potential of Kaempferol Isolated fromInternational journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jesica Ramírez-SantosUnidad de Investigación Médica en Farmacología, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City CP 06720, Mexico.ORCID 0000-0002-2673-4366
Fernando CalzadaUnidad de Investigación Médica en Farmacología, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City CP 06720, Mexico.ORCID 0000-0003-1851-5988
Normand García-HernándezUnidad de Investigación Médica en Genética Humana, UMAE Hospital Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City CP 06725, Mexico.ORCID 0000-0001-6021-8309
Elizabeth BarbosaEscuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City CP 11340, Mexico.ORCID 0000-0002-7111-7922
Claudia VelázquezÁrea Académica de Farmacia, Instituto de Ciencias de la Salud, Universidad Autonoma del Estado de Hidalgo, San Agustin Tlaxiaca CP 42076, Mexico.
Miguel ValdesUnidad de Investigación Médica en Farmacología, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City CP 06720, Mexico.ORCID 0000-0001-7401-303X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Annona genus contains some species used in Mexican traditional medicine for the treatment cancer, including

Indexed as

AnnonaMice, Inbred BALB CMolecular Docking SimulationAnimalsAntineoplastic AgentsAntineoplastic Agents, PhytogenicApoptosisCell Line, TumorFemaleHumansMaleMicePlant ExtractsPolycyclic SesquiterpenesSesquiterpenesAntineoplastic AgentsAntineoplastic Agents, Phytogeniccaryophyllene oxidePlant ExtractsPolycyclic SesquiterpenesSesquiterpenesacute oral toxicityAnnona macroprophyllataantilymphoma activitycaryophyllene oxidemolecular dockingU-937 cells

Identifiers

PMID39769118
PMCPMC11676109

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.